Herbal triplet in treatment of nervous agitation in children

Inga Trompetter1, Bianka Krick, Gabriele Weiss

  • 1PASCOE pharmazeutische Präparate GmbH, Schiffenberger Weg 55, 35394 Giessen, Germany.

Insights

This study found that a plant extract combination effectively improved emotional and behavioral issues in children. The treatment, featuring St. John's Wort, valerian, and passionflower, was well-tolerated and beneficial for nervous agitation.

Area of Science:

  • Pediatric Psychology
  • Herbal Medicine
  • Child Psychiatry

Background:

  • Emotional and behavioral problems are common in children and adolescents.
  • Nervous agitation and agitated depression can significantly impact a child's well-being.
  • Existing treatments may have limitations, necessitating exploration of alternative options.

Purpose of the Study:

  • To investigate the efficacy of a fixed plant extract combination in supporting children with nervous agitation.
  • To evaluate the impact of this herbal treatment on symptoms of agitated depression in pediatric patients.
  • To assess the tolerability and therapeutic success of the plant extract combination.

Main Methods:

  • A multicenter, prospective observational study conducted in 2008.
  • Involved 115 children aged 6-12 years with emotional and behavioral problems.
  • Utilized parent and physician assessments to evaluate symptom improvement over approximately 2 years.

Main Results:

  • Significant improvements were observed in children with attention problems, social withdrawal, and anxiety/depressive symptoms.
  • Physician assessments indicated 81.6-93.9% of children experienced no or mild symptoms for key issues like depression and anxiety.
  • Therapeutic success was not affected by concurrent medications or therapies, and the treatment was well-tolerated.

Conclusions:

  • The fixed plant extract combination, containing St. John's Wort, valerian root, and passionflower herb, effectively supports children with nervous agitation and related symptoms.
  • The herbal treatment demonstrated a favorable safety profile and was well-tolerated by pediatric patients.
  • This study suggests a viable therapeutic option for managing emotional and behavioral problems in children.

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison01:09

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...